By Lewis Krauskopf and Lisa Richwine
NEW YORK (Reuters) - Barr Pharmaceuticals (BRL.N: Quote, Profile, Research, Stock Buzz) is focusing its acquisition priorities on pieces to complement its current base in Europe and on development of a second therapeutic category beyond its current specialty in women's health, the drugmaker's chief executive said on Monday.
New Jersey-based Barr gained a European presence through its $2.5 billion acquisition of Croatia's Pliva last year that also transformed it into one of the world's largest generic drug companies. Barr now has expanded its sales into Germany, Croatia, Russia and Poland.
Some have speculated Barr would seek to expand into Western Europe, but Barr Chief Executive Officer Bruce Downey said he would prefer to "get deeper (in the company's current regions) than think about expanding elsewhere."
"In Europe, I think it would be more of the small pieces that complement or add to what we already have, as opposed to some new geographic expansion," Downey told the Reuters Health Summit in New York by telephone.
Downey said Barr had evaluated 20 companies in the last three years as possible acquisition targets to develop its long-sought second therapeutic category.
The company has two urology products in development, "so by default that may become a second category," Downey said in the interview. He also mentioned ophthalmology, dermatology, neurology and oncology as among the other possibilities.
Although Pliva gave Barr an overseas presence, the boost to its U.S. business is the aspect of the deal most underestimated by investors, Downey said.
For example, with Pliva in the fold, Downey projected that Barr would have 35 to 40 generic injectable products in the United States in three years, up from its current six. The antibiotic azithromycin is one of the bigger injectable products the company has, Downey said. Continued...
© Thomson Reuters 2008. All rights reserved.
| Paper | Aug 20 - 21, 2008 | Manufacturing |
| Japan Investment | Jul 01 - 2, 2008 | Country Summits |
| Global Real Estate | Jun 23 - 25, 2008 | Real Estate |
| Consumer and Retail | Jun 16 - 18, 2008 | Consumer Retail |
| Investment Outlook | Jun 09 - 12, 2008 | Financial Services / Exchanges |
